Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.60 |
| ▸ | CASP2 | P42575 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | NAAA | Q02083 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | CES2 | O00748 | 3/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4147161 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8210761 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8204892 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL2343012 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL4146733 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| N-Ethylpalmitamide SCHEMBL4148137 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL4141617 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL11104897 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8205915 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL8198288 | 1.00 | FAAH (1.00) | FAAHHSP90AA1DNM1CASP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12290525-B2 | 5 alpha dihydrotestosterone formulations and associated methods of use and treatment | CORBOY JR EDWARD DUNNE (US) | 2025-05-06 | — | — | US | disclosed |
| US-20240307410-A1 | 5 ALPHA DIHYDROTESTOSTERONE FORMULATIONS AND ASSOCIATED METHODS OF USE AND TREATMENT | CORBOY JR EDWARD DUNNE (US) | 2024-09-19 | — | — | US | disclosed |
| US-12029741-B1 | 5 beta dihydrotestosterone pharmaceutical formulations and related methods | CORBOY JR EDWARD DUNNE (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240173236-A1 | Topical Testosterone (T) for Promoting Hair Growth-Containing Formulations | CORBOY JR EDWARD DUNNE (US) | 2024-05-30 | — | — | US | disclosed |
| US-20240082262-A1 | TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH | ALLERGAN, INC. | 2024-03-14 | — | — | US | disclosed |
| US-20240067594-A1 | METHODS OF PLASTIC RECYCLING USING HIGHLY EFFICIENT ORGANOCATALYSTS | U. S. DEPARTMENT OF ENERGY | 2024-02-29 | — | — | US | disclosed |
| US-20240033189-A1 | METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION | BASF SE (DE) | 2024-02-01 | — | — | US | disclosed |
| US-11857603-B2 | PTH compounds with low peak-to-trough ratios | ASCENDIS PHARMA BONE DISEASES A/S (DK) | 2024-01-02 | — | — | US | disclosed |
| US-11833238-B2 | Topical testosterone (T) for promoting hair growth-containing formulations | CORBOY JR EDWARD DUNNE (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230381284-A1 | Controlled-Release PTH Compound | ASCENDIS PHARMA BONE DISEASES AS (DK) | 2023-11-30 | — | — | US | disclosed |
| WO-1999026941-A1 | SUBSTITUTED AMIDINOARYL DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | AXYS PHARMACEUTICALS, INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1999026932-A1 | BY AMIDINO GROUP SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTICOAGULANTS | AXYS PHARMACEUTICALS, INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5827863-A | Pyrazole derivatives as angiotensin II antagonists | J. URIACH & CIA, S.A. (ES) | 1998-10-27 | — | — | US | disclosed |
| WO-1998045275-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SERINE PROTEASE, PARTICULARLY TRYPTASE, ACTIVITY | AXYS PHARMACEUTICALS CORPORATION (US) | 1998-10-15 | — | — | WO | disclosed |
| CN-1034331-C | Amines and their use | MITSUI PHARMACEUTICALS LTD (JP) | 1997-03-26 | — | — | CN | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| WO-1996004273-A1 | NEW PYRAZOLE DERIVATIVES AS ANGIOTENSIN II ANTAGONIST | J. URIACH & CIA, S.A. (ES) | 1996-02-15 | — | — | WO | disclosed |
| US-5224987-A | Aqueous carriers with colors and tertiary amide penetrants | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-07-06 | — | — | US | disclosed |
| US-4036712-A | Process for preparing N-(α-alkoxyethyl)-carboxylic acid amides | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240033189-A1 | METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION | CUTA, NISCH, TYR | FAAH 1611/4885HSP90AA1 2502/4885DNM1 2632/4885 |
| US-20230381284-A1 | Controlled-Release PTH Compound | PTH1R, CALCA, CALCB | FAAH 752/4885HSP90AA1 1308/4885DNM1 544/4885 |
| US-20240067594-A1 | METHODS OF PLASTIC RECYCLING USING HIGHLY EFFICIENT ORGANOCATALYSTS | PARG, PNISR, PARN | FAAH 2727/4885HSP90AA1 2081/4885DNM1 3575/4885 |
| US-11857603-B2 | PTH compounds with low peak-to-trough ratios | PTH1R, PTMS, FGF23 | FAAH 2027/4885HSP90AA1 3817/4885DNM1 985/4885 |
| US-20240082262-A1 | TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH | FGF1, CYP21A2, HDGF | FAAH 226/4885HSP90AA1 2694/4885DNM1 3200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.